About endra life sciences inc - NDRA
ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.
NDRA At a Glance
ENDRA Life Sciences, Inc.
3600 Green Court
Ann Arbor, Michigan 48105-1570
| Phone | 1-734-335-0468 | Revenue | 0.00 | |
| Industry | Medical Specialties | Net Income | -11,507,947.00 | |
| Sector | Health Technology | Employees | 21 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
NDRA Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 1.313 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.077 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | -0.424 |
NDRA Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -547,997.476 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
NDRA Liquidity
| Current Ratio | 5.673 |
| Quick Ratio | 5.673 |
| Cash Ratio | 5.336 |
NDRA Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -205.38 |
| Return on Equity | -280.021 |
| Return on Total Capital | -365.937 |
| Return on Invested Capital | -258.638 |
NDRA Capital Structure
| Total Debt to Total Equity | 22.826 |
| Total Debt to Total Capital | 18.584 |
| Total Debt to Total Assets | 13.126 |
| Long-Term Debt to Equity | 19.04 |
| Long-Term Debt to Total Capital | 15.501 |